BCMA/TNFRSF17 , His & Avi, Human

BCMA/TNFRSF17 , His & Avi, Human

B-cell maturation antigen (BCMA or BCM), also known as tumor necrosis factor receptor superfamily member 17 (TNFRSF17), is a protein that in humans is encoded by the TNFRSF17 gene. TNFRSF17 is a cell surface receptor of the TNF receptor superfamily which recognizes B-cell activating factor (BAFF).
Z03846
¥68,875.00

Ask us a question
Product Introduction
Species Human
Protein Construction
BCMA/TNFRSF17 (Met1-Ala54)
Accession # Q02223-1		 His Avi
N-term C-term
Purity > 95% as determined by Bis-Tris PAGE
> 95% as determined by HPLC
Endotoxin Level Less than 1EU per μg by the LAL method.
Biological Activity Immobilized BCMA/TNFRSF17, His & Avi, Human (Cat.No.: Z03846) at 1 μg/ml (100μl/Well) on the plate can bind Biotinylated Human BAFF, His Tag.
Expression System HEK293
Theoretical Molecular Weight 8.9 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 12 kDa and 15-17 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from a 0.22 μm filtered solution in PBS, pH 7.4.
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles.

Background
Target Background BCMA (B-cell maturation antigen), also called TNFRSF17, is encoded by the TNFRSF17 gene. It acts as a cell surface receptor of the TNF receptor superfamily. BCMA recognizes B-cell activating factor (BAFF). It interacts with the B-cell activating factor TNFSF13B.
Synonyms CD269; TNFRSF17; BCMA; BCM; TNFRSF13A

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.